No paralogue variants have been mapped to residue 161 for CACNA1C.
CACNA1C | LLTIFANCVALAIYIPFPEDDSNATNSNLE>R<VEYLFLI-IFTVEAFLKVIAYGLLFHPNAY | 190 |
CACNA1A | LATIIANCIVLALEQHLPDDDKTPMSERLD>D<TEPYFIG-IFCFEAGIKIIALGFAFHKGSY | 164 |
CACNA1B | LATIIANCIVLALEQHLPDGDKTPMSERLD>D<TEPYFIG-IFCFEAGIKIIALGFVFHKGSY | 161 |
CACNA1D | LLAIFANCVALAIYIPFPEDDSNSTNHNLE>K<VEYAFLI-IFTVETFLKIIAYGLLLHPNAY | 192 |
CACNA1E | LATIIANCIVLALEQHLPEDDKTPMSRRLE>K<TEPYFIG-IFCFEAGIKIVALGFIFHKGSY | 155 |
CACNA1F | LLTIFANCVALGVYIPFPEDDSNTANHNLE>Q<VEYVFLV-IFTVETVLKIVAYGLVLHPSAY | 158 |
CACNA1G | MLVILLNCVTLGMFRPCEDIACDSQRCRIL>Q<AFDDFIFAFFAVEMVVKMVALGI-FGKKCY | 147 |
CACNA1H | MLVIMLNCVTLGMFRPCEDVECGSERCNIL>E<AFDAFIFAFFAVEMVIKMVALGL-FGQKCY | 166 |
CACNA1I | MLVILLNCVTLGMYQPCDDMDCLSDRCKIL>Q<VFDDFIFIFFAMEMVLKMVALGI-FGKKCY | 145 |
CACNA1S | LLTIFANCVALAVYLPMPEDDNNSLNLGLE>K<LEYFFLI-VFSIEAAMKIIAYGFLFHQDAY | 117 |
SCN10A | TVTILVNCVCMTRT------D-LPE----->K<IEYVFTV-IYTFEALIKILARGFCLNEFTY | 184 |
SCN11A | IGTVIINCVFMATGPA-K--NSNSNNT--D>I<AECVFTG-IYIFEALIKILARGFILDEFSF | 190 |
SCN1A | MCTILTNCVFMTMS------N-PPDWT--K>N<VEYTFTG-IYTFESLIKIIARGFCLEDFTF | 185 |
SCN2A | MCTILTNCVFMTMS------N-PPDWT--K>N<VEYTFTG-IYTFESLIKILARGFCLEDFTF | 186 |
SCN3A | MCTILTNCVFMTLS------N-PPDWT--K>N<VEYTFTG-IYTFESLIKILARGFCLEDFTF | 185 |
SCN4A | MITILTNCVFMTMS------D-PPPWS--K>N<VEYTFTG-IYTFESLIKILARGFCVDDFTF | 188 |
SCN5A | MCTILTNCVFMAQH------D-PPPWT--K>Y<VEYTFTA-IYTFESLVKILARGFCLHAFTF | 188 |
SCN7A | LISVLIDCVFMSLT------N-LPKWR--P>V<LENTLLG-IYTFEILVKLFARGVWAGSFSF | 175 |
SCN8A | MCTILTNCVFMTFS------N-PPDWS--K>N<VEYTFTG-IYTFESLVKIIARGFCIDGFTF | 189 |
SCN9A | MCTILTNCIFMTMN------N-PPDWT--K>N<VEYTFTG-IYTFESLVKILARGFCVGEFTF | 183 |
cons | > < |
Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
---|---|---|---|---|---|
p.R161Q | c.482G>A | Putative Benign | SIFT: Polyphen: |